Compare APGE & LPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APGE | LPX |
|---|---|---|
| Founded | 2022 | 1973 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Forest Products |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.9B |
| IPO Year | 2023 | 1994 |
| Metric | APGE | LPX |
|---|---|---|
| Price | $134.14 | $71.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 7 |
| Target Price | ★ $109.67 | $105.29 |
| AVG Volume (30 Days) | ★ 1.2M | 1.1M |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.67% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.39 |
| Revenue | N/A | ★ $2,708,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $11.23 |
| P/E Ratio | ★ N/A | $184.13 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $34.34 | $66.12 |
| 52 Week High | $134.46 | $102.86 |
| Indicator | APGE | LPX |
|---|---|---|
| Relative Strength Index (RSI) | 79.86 | 44.09 |
| Support Level | $80.52 | $68.71 |
| Resistance Level | N/A | $77.35 |
| Average True Range (ATR) | 0.27 | 2.89 |
| MACD | -1.62 | -0.15 |
| Stochastic Oscillator | 70.00 | 23.28 |
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
Louisiana-Pacific Corp is an oriented strand board producer and also offers engineered wood siding used in home construction and repair and remodel projects. The Siding business of the company serves different markets with a broad product portfolio of engineered wood siding, trim, soffit, and fascia. The Company operates through three operating segments: Siding, OSB, and LP South America (LPSA). The company generates majority of its revenue from siding segment.